查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1541732

2024-2032 年按測試類型（巴氏檢測、HPV 檢測、子宮頸活體組織切片、陰道鏡檢查等）、年齡層（20 至 35 歲、35 歲以上）和地區分類的子宮頸癌診斷市場報告

Cervical Cancer Diagnostics Market Report by Test Type (Pap Testing, HPV Testing, Cervical Biopsies, Colposcopy, and Others), Age Group (20 to 35 Years, Above 35 Years), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球IMARC Group宮頸癌診斷市場規模達80億美元。

子宮頸癌診斷依賴一系列先進的實驗室檢查、工具和程序來評估異常細胞或人類乳突病毒 (HPV) 株。它們是透過採集透過錐切術、穿刺活體組織切片、子宮頸內膜刮除術和電線環獲得的組織樣本來進行的，以便在陰道鏡檢查期間對子宮頸進行徹底檢查。檢測後，進行血液、胸部X光、全身電腦斷層掃描（CT）掃描、磁振造影（MRI）、正子斷層掃描（PET）掃描以及膀胱和直腸目視檢查等測試來確定疾病階段。

被診斷患有梅毒、披衣菌、淋病和後天免疫缺乏症候群 (HIV/AIDS) 等性傳染感染 (STI) 的人數大幅增加，導致全球 HPV 感染的風險不斷上升。再加上吸菸者數量的增加，增加了罹患子宮頸癌的機會，這是推動市場成長的關鍵因素之一。此外，人們對早期診斷的認知不斷提高，鼓勵採用可提供快速、準確檢測結果的 HPV 家庭檢測試劑盒。有利的報銷政策的存在也支持了市場的成長。除此之外，對個人化治療計劃的日益偏好正在增加對子宮頸癌診斷的需求。此外，一系列其他治療方案的出現，包括手術、放射治療、化療、錐形活體組織切片、免疫治療和子宮頸切除術，也促進了市場的成長。此外，對開發低成本和高效測試產品的日益重視預計將推動市場成長。

本報告回答的關鍵問題

  • 全球子宮頸癌診斷市場有多大？ 2024-2032年全球子宮頸癌診斷市場的預期成長率是多少？
  • 推動全球子宮頸癌診斷市場的關鍵因素是什麼？
  • COVID-19 對全球子宮頸癌診斷市場有何影響？
  • 根據測試類型，全球子宮頸癌診斷市場的細分如何？
  • 全球子宮頸癌診斷市場的關鍵區域有哪些？
  • 全球子宮頸癌診斷市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球子宮頸癌診斷市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按測試類型

  • 巴氏測試
    • 市場趨勢
    • 市場預測
  • HPV檢測
    • 市場趨勢
    • 市場預測
  • 子宮頸活體組織切片
    • 市場趨勢
    • 市場預測
  • 陰道鏡檢查
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依年齡段

  • 20至35歲
    • 市場趨勢
    • 市場預測
  • 35歲以上
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 9 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Arbor Vita Corporation
    • Becton, Dickinson and Company
    • Cooper Surgical Inc.
    • F. Hoffmann-La Roche AG
    • Guided Therapeutics Inc.
    • Hologic Inc.
    • Qiagen
    • Quest Diagnostics Incorporated
    • Siemens Healthcare GmbH
Product Code: SR112024A3175

The global cervical cancer diagnostics market size reached US$ 8.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.3 Billion by 2032, exhibiting a growth rate (CAGR) of 4.8% during 2024-2032.

Cervical cancer diagnostics rely on a series of advanced laboratory tests, tools and procedures to evaluate abnormal cells or strains of the human papillomavirus (HPV). They are performed by taking a sample of the tissue obtained through conization, punch biopsy, endocervical curettage and the electrical wire loop for a thorough examination of the cervix during colposcopy. After detection, tests like blood, chest X-ray, body computed tomography (CT) scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scan and visual examination of bladder and rectum are conducted to determine the disease stage.

A considerable rise in the number of individuals diagnosed with sexually transmitted infections (STIs), such as syphilis, chlamydia, gonorrhea and acquired immune deficiency syndrome (HIV/AIDS), is escalating the risk of HPV infection worldwide. This, along with the growing number of smokers, which increases the chances of developing cervical cancer, represents one of the key factors bolstering the market growth. Furthermore, the rising awareness about early diagnosis is encouraging the adoption of HPV home testing kits that provide quick and accurate test results. The presence of favorable reimbursement policies also supports the market growth. Apart from this, rising preferences for personalized treatment plans are escalating the demand for cervical cancer diagnostics. Additionally, the availability of a range of other treatment options, including surgery, radiation therapy, chemotherapy, cone biopsy, immunotherapy and trachelectomy, is contributing to the market growth. Moreover, the growing emphasis on developing low-cost and efficient testing products is anticipated to fuel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cervical cancer diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on test type and age group.

Breakup by Test Type:

Pap Testing

HPV Testing

Cervical Biopsies

Colposcopy

Others

Breakup by Age Group:

20 to 35 years

Above 35 years

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company, Cooper Surgical Inc., F. Hoffmann-La Roche AG, Guided Therapeutics Inc., Hologic Inc., Qiagen, Quest Diagnostics Incorporated and Siemens Healthcare GmbH.

Key Questions Answered in This Report

  • 1. How big is the global cervical cancer diagnostics market?
  • 2. What is the expected growth rate of the global cervical cancer diagnostics market during 2024-2032?
  • 3. What are the key factors driving the global cervical cancer diagnostics market?
  • 4. What has been the impact of COVID-19 on the global cervical cancer diagnostics market?
  • 5. What is the breakup of the global cervical cancer diagnostics market based on the test type?
  • 6. What are the key regions in the global cervical cancer diagnostics market?
  • 7. Who are the key players/companies in the global cervical cancer diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cervical Cancer Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Pap Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 HPV Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cervical Biopsies
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Colposcopy
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 20 to 35 years
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Above 35 years
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Arbor Vita Corporation
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Becton, Dickinson and Company
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Cooper Surgical Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Guided Therapeutics Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 SWOT Analysis
    • 13.3.7 Hologic Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Qiagen
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Quest Diagnostics Incorporated
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Siemens Healthcare GmbH
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Cervical Cancer Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Cervical Cancer Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Cervical Cancer Diagnostics Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: Cervical Cancer Diagnostics Market: Breakup by Age Group (in %), 2023
  • Figure 6: Global: Cervical Cancer Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Cervical Cancer Diagnostics (Pap Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Cervical Cancer Diagnostics (Pap Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Cervical Cancer Diagnostics (HPV Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Cervical Cancer Diagnostics (HPV Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Cervical Cancer Diagnostics (Colposcopy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Cervical Cancer Diagnostics (Colposcopy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Cervical Cancer Diagnostics (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Cervical Cancer Diagnostics (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Cervical Cancer Diagnostics (20 to 35 years) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Cervical Cancer Diagnostics (20 to 35 years) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Cervical Cancer Diagnostics (Above 35 years) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Cervical Cancer Diagnostics (Above 35 years) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: North America: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: North America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: United States: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: United States: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Canada: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Canada: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Asia-Pacific: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Asia-Pacific: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: China: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: China: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Japan: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Japan: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: India: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: India: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: South Korea: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: South Korea: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Australia: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Australia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Indonesia: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Indonesia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Europe: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Europe: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Germany: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Germany: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: France: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: France: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: United Kingdom: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: United Kingdom: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Italy: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Italy: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Spain: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Spain: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Russia: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Russia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Latin America: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Latin America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Brazil: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Brazil: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Mexico: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Mexico: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Middle East and Africa: Cervical Cancer Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Middle East and Africa: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Middle East and Africa: Cervical Cancer Diagnostics Market: Breakup by Country (in %), 2023
  • Figure 70: Global: Cervical Cancer Diagnostics Industry: SWOT Analysis
  • Figure 71: Global: Cervical Cancer Diagnostics Industry: Value Chain Analysis
  • Figure 72: Global: Cervical Cancer Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cervical Cancer Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 3: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
  • Table 4: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Cervical Cancer Diagnostics Market: Competitive Structure
  • Table 6: Global: Cervical Cancer Diagnostics Market: Key Players